Prophylactic versus Preemptive modified donor lymphocyte infusion for high-risk acute leukemia after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study

Sorafenib maintenance after allogeneic haemopoietic stem-cell transplantation in patients with FLT3-ITD acute myeloid leukaemia: long-term follow-up of an open-label, multicentre, randomised, phase 3 trial

(2023) Li Xuan et al.   Lancet Haematology

Combining blinatumomab and donor lymphocyte infusion in B-ALL patients relapsing after allogeneic hematopoietic cell transplantation: a study of the SFGM-TC

(2022) Paul Chauvet et al.   BONE MARROW TRANSPLANTATION

Defining the Role of Donor Lymphocyte Infusion in High-Risk Hematologic Malignancies

(2021) Christoph Schmid et al.   JOURNAL OF CLINICAL ONCOLOGY

Pre-emptive use of Sorafenib combined with DLI post HSCT in AML FLT3+: a single center experience

(2021) Antonella Bruzzese et al.   BONE MARROW TRANSPLANTATION

Mixed T cell lineage chimerism in acute leukemia/MDS using pre-emptive donor lymphocyte infusion strategy—Is it prognostic?—a single-center retrospective study

(2021) Vipul Sheth et al.   Blood Cancer Journal

Clonal expansion of CD8+ T cells reflects graft-versus-leukemia activity and precedes durable remission following DLI

(2021) Christian R Schultze-Florey et al.   Blood Advances

Venetoclax plus azacitidine and donor lymphocyte infusion in treating acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation

(2021) Peng Zhao et al.   ANNALS OF HEMATOLOGY

Sequential administration of low dose 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation (SCT): a prospective study from the Belgian Hematology Society (BHS)

(2021) Xavier Poiré et al.   BONE MARROW TRANSPLANTATION

Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia

(2021) Christoph Schmid et al.   BONE MARROW TRANSPLANTATION

Mapping the evolution of T cell states during response and resistance to adoptive cellular therapy

(2021) Pavan Bachireddy et al.   Cell Reports

Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3–Internal Tandem Duplication Mutation (SORMAIN)

(2020) Andreas Burchert et al.   JOURNAL OF CLINICAL ONCOLOGY

Prophylactic modified donor lymphocyte infusion after low-dose ATG-F-based haploidentical HSCT with myeloablative conditioning in high-risk acute leukemia: a matched-pair analysis

(2020) Luxin Yang et al.   BONE MARROW TRANSPLANTATION

PD1 inhibitor in combination with 5-azacytidine and low-dose DLI for the successful treatment of AML patients who relapsed after transplantation

(2020) Chong-Sheng Qian et al.   BONE MARROW TRANSPLANTATION

Effect of rhG-CSF Combined With Decitabine Prophylaxis on Relapse of Patients With High-Risk MRD-Negative AML After HSCT: An Open-Label, Multicenter, Randomized Controlled Trial

(2020) Lei Gao et al.   JOURNAL OF CLINICAL ONCOLOGY

Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome

(2019) Thierry Guillaume et al.   BONE MARROW TRANSPLANTATION

Managing post allograft relapse of myeloid neoplasms: azacitidine and donor lymphocyte infusions as salvage therapy

(2019) John Claiborne et al.   LEUKEMIA & LYMPHOMA

Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the acute leukemia working party of the EBMT

(2019) Bhagirathbhai Dholaria et al.   HAEMATOLOGICA

Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research

(2019) Aleksandr Lazaryan et al.   HAEMATOLOGICA

Reversal of T Cell Exhaustion by the First Donor Lymphocyte Infusion Is Associated with the Persistently Effective Antileukemic Responses in Patients with Relapsed AML after Allo-HSCT

(2018) Long Liu et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Epidemiology and biology of relapse after stem cell transplantation

(2018) Mary Horowitz et al.   BONE MARROW TRANSPLANTATION

Donor lymphocyte infusion for prevention of relapse after unmanipulated haploidentical PBSCT for very high-risk hematologic malignancies

(2018) Xiao-Ning Gao et al.   ANNALS OF HEMATOLOGY

Prophylactic donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantation for high risk haematological malignancies: a retrospective bicentric analysis of serial infusions of increasing doses of CD3+ cells

(2018) Raphael Cauchois et al.   BRITISH JOURNAL OF HAEMATOLOGY

Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia - a matched pair analysis by the Acute Leukaemia Working Party of EBMT

(2018) Christoph Schmid et al.   BRITISH JOURNAL OF HAEMATOLOGY

Improved Outcome of Refractory/Relapsed Acute Myeloid Leukemia after Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation with Myeloablative Conditioning and Early Prophylactic Granulocyte Colony-Stimulating Factor–Mobilized Donor Lymphocyte Infusions

(2016) Sarita Rani Jaiswal et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the

(2016) Sebastian Giebel et al.   CANCER

T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT

(2014) Y. Luo et al.   BLOOD

Chemotherapy followed by modified donor lymphocyte infusion as a treatment for relapsed acute leukemia after haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: superior outcomes compared with chemotherapy alone and a

(2013) Chen-Hua Yan et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)

(2012) O. C. Goodyear et al.   BLOOD

Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation

(2012) C.-H. Yan et al.   BLOOD

Prevention of relapse using DLI can increase survival following HLA-identical transplantation in patients with advanced-stage acute leukemia: a multi-center study

(2012) Yu Wang et al.   CLINICAL TRANSPLANTATION

The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells

(2009) C Flotho et al.   LEUKEMIA

Modified Donor Lymphocyte Infusion (DLI) for the Prophylaxis of Leukemia Relapse after Hematopoietic Stem Cell Transplantation in Patients with Advanced Leukemia—Feasibility and Safety Study

(2008) Xiao-Jun Huang et al.   JOURNAL OF CLINICAL IMMUNOLOGY